Page last updated: 2024-08-21

alpha-aminopyridine and Hyperlipemia

alpha-aminopyridine has been researched along with Hyperlipemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Bauer, TM; Calella, AM; de Marinis, F; Felip, E; Goto, Y; Kim, DW; Liu, G; Mazieres, J; Mok, T; Peltz, G; Polli, A; Shaw, AT; Solomon, BJ; Thurm, H	1
Akhter, N; Kanwar, YS; McGee, K; Stone, NJ; Villaflor, V; Wadhwani, S	1

Reviews

1 review(s) available for alpha-aminopyridine and Hyperlipemia

Article	Year
A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:8 Topics: Aminopyridines; Carcinoma, Non-Small-Cell Lung; Female; Humans; Hyperlipidemias; Lactams; Lung Neoplasms; Middle Aged; Pyrazoles	2021

Article

Year

A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:8

Topics: Aminopyridines; Carcinoma, Non-Small-Cell Lung; Female; Humans; Hyperlipidemias; Lactams; Lung Neoplasms; Middle Aged; Pyrazoles

2021

Trials

1 trial(s) available for alpha-aminopyridine and Hyperlipemia

Article	Year
First-Line Lorlatinib or Crizotinib in Advanced The New England journal of medicine, 2020, 11-19, Volume: 383, Issue:21 Topics: Adult; Aged; Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Female; Humans; Hyperlipidemias; Intention to Treat Analysis; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Mutation; Pyrazoles; Survival Analysis	2020

Article

Year

First-Line Lorlatinib or Crizotinib in Advanced

The New England journal of medicine, 2020, 11-19, Volume: 383, Issue:21

Topics: Adult; Aged; Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Female; Humans; Hyperlipidemias; Intention to Treat Analysis; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Mutation; Pyrazoles; Survival Analysis

2020